Biofil Chemicals Valuation
| BIOFILCHEM | 62.77 0.86 1.39% |
At this time, the firm appears to be overvalued. Biofil Chemicals Pha shows a prevailing Real Value of USD57.35 per share. The current price of the firm is USD62.77. Our model approximates the value of Biofil Chemicals Pha from analyzing the firm fundamentals such as Current Valuation of 1.01 B, profit margin of 0.01 %, and Return On Equity of 0.04 as well as examining its technical indicators and probability of bankruptcy.
Price Book 5.4766 | Enterprise Value 1 B | Enterprise Value Ebitda 94.5036 | Price Sales 2.221 | Trailing PE 190.2121 |
Overvalued
Today
Please note that Biofil Chemicals' price fluctuation is very steady at this time. Calculation of the real value of Biofil Chemicals Pha is based on 3 months time horizon. Increasing Biofil Chemicals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Biofil Chemicals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biofil Stock. However, Biofil Chemicals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 62.77 | Real 57.35 | Hype 62.77 | Naive 60.72 |
The real value of Biofil Stock, also known as its intrinsic value, is the underlying worth of Biofil Chemicals Pha Company, which is reflected in its stock price. It is based on Biofil Chemicals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Biofil Chemicals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Biofil Chemicals Pharmaceuticals helps investors to forecast how Biofil stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biofil Chemicals more accurately as focusing exclusively on Biofil Chemicals' fundamentals will not take into account other important factors: Biofil Chemicals Cash |
|
Biofil Chemicals Total Value Analysis
Biofil Chemicals Pharmaceuticals is currently forecasted to have takeover price of 1.01 B with market capitalization of 1.02 B, debt of 4.39 M, and cash on hands of 260 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Biofil Chemicals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.01 B | 1.02 B | 4.39 M | 260 K |
Biofil Chemicals Investor Information
About 60.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Based on the key indicators related to Biofil Chemicals' liquidity, profitability, solvency, and operating efficiency, Biofil Chemicals Pharmaceuticals is performing exceptionally good at this time. It has a great probability to report excellent financial results in December.Biofil Chemicals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biofil Chemicals has an asset utilization ratio of 85.03 percent. This indicates that the Company is making USD0.85 for each dollar of assets. An increasing asset utilization means that Biofil Chemicals Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Biofil Chemicals Ownership Allocation
Biofil Chemicals holds a total of 16.27 Million outstanding shares. Biofil Chemicals Pharmaceuticals retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Biofil Chemicals Profitability Analysis
The company reported the revenue of 400.35 M. Net Income was 7.09 M with profit before overhead, payroll, taxes, and interest of 25.63 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Biofil Chemicals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Biofil Chemicals and how it compares across the competition.
About Biofil Chemicals Valuation
The stock valuation mechanism determines Biofil Chemicals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Biofil Chemicals. We calculate exposure to Biofil Chemicals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biofil Chemicals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 25.3 M | 21.7 M |
Complementary Tools for Biofil Stock analysis
When running Biofil Chemicals' price analysis, check to measure Biofil Chemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofil Chemicals is operating at the current time. Most of Biofil Chemicals' value examination focuses on studying past and present price action to predict the probability of Biofil Chemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofil Chemicals' price. Additionally, you may evaluate how the addition of Biofil Chemicals to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |